In vitro experiments further demonstrated TEV-induced immune alterations, and in vivo findings suggested that TEVs enriched in mTOR support granulocyte-colony stimulating factor (G-CSF) release, contributing to tumor immune suppression and metastasis growth. This evidence concerns the gene CSF3 and neoplasm.